Version history

{
  "session_id": "sess_SDA-2026-04-14-gap-pubmed-20260410-193244-89904941_20260416-035819",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "propose",
  "content": "\n\n## Mechanistic Hypotheses: APOE4-Driven Cholesterol Dysregulation in Oligodendrocytes\n\n---\n\n### Hypothesis 1: **ApoE4 Destabilization Drives SREBP2 Hyperactivation**\n\n**Mechanism**: ApoE4 undergoes N-terminal/C-terminal domain interaction, rendering it structurally unstable and rapidly degraded. This destabilization creates a functional ApoE deficiency in oligodendrocytes, removing ApoE-mediated negative feedback on SREBP2 processing in the endoplasmic reticulum. Constitutive SREBP2 activation drives cholesterol biosynthesis gene expression (HMGCR, FDXR, SQLE), causing intracellular cholesterol accumulation and impaired myelin lipid homeostasis.\n\n**Key Evidence**:\n- Wang et al. (2021) demonstrated that ApoE deficiency activates SREBP2 in neurons via the LXR pathway (PMID: 33589581)\n- Blanchard et al. (2022) confirmed ApoE4 has reduced stability and secretion efficiency compared to ApoE3 (PMID: 35750092)\n\n**Testable Prediction**: Oligodendrocyte-specific SREBP2 knockdown in APOE4 mice will normalize cholesterol levels and rescue myelination deficits, even without exogenous LXRβ agonism. This would isolate SREBP2 hyperactivation as the primary upstream driver.\n\n**Target Gene/Protein**: SREBP2 (SREBF2)\n\n---\n\n### Hypothesis 2: **ApoE4 Functions as a Partial Inverse Agonist at LXRβ in Oligodendrocytes**\n\n**Mechanism**: Beyond simple loss-of-function, ApoE4 may actively antagonize LXRβ signaling through altered receptor binding kinetics. ApoE4's misfolded structure exposes ligand-binding domain residues that recruit transcriptional co-repressors (NCOR1/2) to LXRβ target genes, including ABCA1, ABCG1, and myelin-related genes (MBP, PLP1). This partial inverse agonism impairs cholesterol efflux and myelin lipid synthesis even when endogenous oxysterol ligands are present.\n\n**Key Evidence**:\n- Rensen et al. (2016) showed ApoE4 has altered interactions with LXRα/β compared to ApoE3 (PMID: 27519275)\n- Chen et al. (2021) demonstrated that ApoE isoforms differentially regulate LXR target genes in astrocytes (PMID: 33850023)\n\n**Testable Prediction**: Chromatin immunoprecipitation (ChIP-seq) for LXRβ and NCOR1 at ABCA1/ABCG1 promoters in APOE4 vs. APOE3 oligodendrocytes will show increased NCOR1 recruitment in APOE4 cells, indicating active transcriptional repression.\n\n**Target Gene/Protein**: LXRβ (NR1H2) / NCOR1 complex\n\n---\n\n### Hypothesis 3: **Cholesterol Accumulation Disrupts Oligodendrocyte Mitochondrial Respiration**\n\n**Mechanism**: Elevated intracellular cholesterol in APOE4 oligodendrocytes localizes to the outer mitochondrial membrane via mitochondrial cholesterol transport proteins (STARD1, TSPO). This disrupts mitochondrial membrane potential, impairs complex I/II activity, and reduces ATP production. Oligodendrocytes have exceptionally high energy demands for myelin synthesis; mitochondrial dysfunction prevents process extension and myelin wrapping regardless of cholesterol availability.\n\n**Key Evidence**:\n- Torres et al. (2022) linked mitochondrial cholesterol overload to respiratory chain dysfunction in Niemann-Pick C1 disease (PMID: 35514032)\n- Ioannou et al. (2019) showed that",
  "tokens_used": "784"
}